Heide Christine. Patterson, et.al., Cytoplasmic Ig alpha serine/threonines fine-tune Ig alpha tyrosine phosphorylation and limit bone marrow plasma cell formation., Journal of immunology (Baltimore, Md. : 1950), 2011, 187

http://rdf.ncbi.nlm.nih.gov/pubmed/21841126

Heide Christine. Patterson, et.al., Cytoplasmic Ig alpha serine/threonines fine-tune Ig alpha tyrosine phosphorylation and limit bone marrow plasma cell formation., Journal of immunology (Baltimore, Md. : 1950), 2011, 187

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• Cd79a<tm1Rsky>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5301876

class

http://purl.org/net/cito/citesAsAuthority

• Cd79a<tm1Rsky>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5301876

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• increased pro-B cell number_Cd79a<tm1.1Cgn>/Cd79a<tm1.1Cgn>,Cd79b<tm1Gzmn>/Cd79b<+>
  http://metadb.riken.jp/0008186I129P2OlaHsdCd79atm11CgnCd79atm11CgnCd79btm1GzmnCd79bCd79bCd79btm1GzmnCd79atm11Cgn
• increased transitional stage B cell number_Cd79a<tm1Rsky>/Cd79a<tm1Rsky>
  http://metadb.riken.jp/0008189IC57BL6Cd79atm1RskyCd79atm1RskyCd79atm1Rsky
• increased anti-single stranded DNA antibody level_Cd79a<tm1Rsky>/Cd79a<tm1Rsky>
  http://metadb.riken.jp/0004771IC57BL6Cd79atm1RskyCd79atm1RskyCd79atm1Rsky
• decreased pre-B cell number_Cd79a<tm1.1Cgn>/Cd79a<tm1.1Cgn>,Cd79b<tm1Gzmn>/Cd79b<+>
  http://metadb.riken.jp/0008209I129P2OlaHsdCd79atm11CgnCd79atm11CgnCd79btm1GzmnCd79bCd79bCd79btm1GzmnCd79atm11Cgn
• increased IgG2b level_Cd79a<tm1Rsky>/Cd79a<tm1Rsky>
  http://metadb.riken.jp/0008501IC57BL6Cd79atm1RskyCd79atm1RskyCd79atm1Rsky
• decreased B cell number_Cd79a<tm1.1Cgn>/Cd79a<tm1.1Cgn>,Cd79b<tm1Gzmn>/Cd79b<+>
  http://metadb.riken.jp/0005017I129P2OlaHsdCd79atm11CgnCd79atm11CgnCd79btm1GzmnCd79bCd79bCd79btm1GzmnCd79atm11Cgn
• decreased mature B cell number_Cd79a<tm1Rsky>/Cd79a<tm1Rsky>
  http://metadb.riken.jp/0008211IC57BL6Cd79atm1RskyCd79atm1RskyCd79atm1Rsky
• decreased B cell number_Cd79a<tm1.1Cgn>/Cd79a<tm1.1Cgn>,Cd79b<tm1Gzmn>/Cd79b<tm1Gzmn>
  http://metadb.riken.jp/0005017I129P2OlaHsdCd79atm11CgnCd79atm11CgnCd79btm1GzmnCd79btm1GzmnCd79atm11CgnCd79btm1Gzmn
• decreased marginal zone B cell number_Cd79a<tm1Rsky>/Cd79a<tm1Rsky>
  http://metadb.riken.jp/0008182IC57BL6Cd79atm1RskyCd79atm1RskyCd79atm1Rsky
• increased pro-B cell number_Cd79a<tm1.1Cgn>/Cd79a<tm1.1Cgn>,Cd79b<tm1Gzmn>/Cd79b<tm1Gzmn>
  http://metadb.riken.jp/0008186I129P2OlaHsdCd79atm11CgnCd79atm11CgnCd79btm1GzmnCd79btm1GzmnCd79atm11CgnCd79btm1Gzmn
• decreased IgG3 level_Cd79a<tm1Rsky>/Cd79a<tm1Rsky>
  http://metadb.riken.jp/0008498IC57BL6Cd79atm1RskyCd79atm1RskyCd79atm1Rsky
• absent pre-B cells_Cd79a<tm1.1Cgn>/Cd79a<tm1.1Cgn>,Cd79b<tm1Gzmn>/Cd79b<tm1Gzmn>
  http://metadb.riken.jp/0000238I129P2OlaHsdCd79atm11CgnCd79atm11CgnCd79btm1GzmnCd79btm1GzmnCd79atm11CgnCd79btm1Gzmn
• increased IgG2c level_Cd79a<tm1Rsky>/Cd79a<tm1Rsky>
  http://metadb.riken.jp/0008896IC57BL6Cd79atm1RskyCd79atm1RskyCd79atm1Rsky
• decreased IgG2b level_Cd79a<tm1Rsky>/Cd79a<tm1Rsky>
  http://metadb.riken.jp/0008497IC57BL6Cd79atm1RskyCd79atm1RskyCd79atm1Rsky
• increased transitional stage T2 B cell number_Cd79a<tm1Rsky>/Cd79a<tm1Rsky>
  http://metadb.riken.jp/0009925IC57BL6Cd79atm1RskyCd79atm1RskyCd79atm1Rsky
• increased transitional stage T1 B cell number_Cd79a<tm1Rsky>/Cd79a<tm1Rsky>
  http://metadb.riken.jp/0009922IC57BL6Cd79atm1RskyCd79atm1RskyCd79atm1Rsky
• increased immature B cell number_Cd79a<tm1Rsky>/Cd79a<tm1Rsky>
  http://metadb.riken.jp/0008214IC57BL6Cd79atm1RskyCd79atm1RskyCd79atm1Rsky
• increased pre-B cell number_Cd79a<tm1Rsky>/Cd79a<tm1Rsky>
  http://metadb.riken.jp/0003132IC57BL6Cd79atm1RskyCd79atm1RskyCd79atm1Rsky
• abnormal B cell differentiation_Cd79a<tm1.1Cgn>/Cd79a<tm1.1Cgn>,Cd79b<tm1Gzmn>/Cd79b<tm1Gzmn>
  http://metadb.riken.jp/0002144I129P2OlaHsdCd79atm11CgnCd79atm11CgnCd79btm1GzmnCd79btm1GzmnCd79atm11CgnCd79btm1Gzmn
• abnormal humoral immune response_Cd79a<tm1Rsky>/Cd79a<tm1Rsky>
  http://metadb.riken.jp/0001800IC57BL6Cd79atm1RskyCd79atm1RskyCd79atm1Rsky
• decreased IgG2c level_Cd79a<tm1Rsky>/Cd79a<tm1Rsky>
  http://metadb.riken.jp/0008897IC57BL6Cd79atm1RskyCd79atm1RskyCd79atm1Rsky
• decreased pre-B cell number_Cd79a<tm1.1Cgn>/Cd79a<+>,Cd79b<tm1Gzmn>/Cd79b<tm1Gzmn>
  http://metadb.riken.jp/0008209I129P2OlaHsdCd79atm11CgnCd79aCd79btm1GzmnCd79btm1GzmnCd79atm11CgnCd79aCd79btm1Gzmn
• increased pro-B cell number_Cd79a<tm1.1Cgn>/Cd79a<+>,Cd79b<tm1Gzmn>/Cd79b<tm1Gzmn>
  http://metadb.riken.jp/0008186I129P2OlaHsdCd79atm11CgnCd79aCd79btm1GzmnCd79btm1GzmnCd79atm11CgnCd79aCd79btm1Gzmn
• decreased B cell number_Cd79a<tm1.1Cgn>/Cd79a<+>,Cd79b<tm1Gzmn>/Cd79b<tm1Gzmn>
  http://metadb.riken.jp/0005017I129P2OlaHsdCd79atm11CgnCd79aCd79btm1GzmnCd79btm1GzmnCd79atm11CgnCd79aCd79btm1Gzmn
• increased transitional stage T3 B cell number_Cd79a<tm1Rsky>/Cd79a<tm1Rsky>
  http://metadb.riken.jp/0010229IC57BL6Cd79atm1RskyCd79atm1RskyCd79atm1Rsky